In the work “Analysis of Genomic Alterations Associated with Recurrence in Early Stage Her2-Positive Breast Cancer”, gene expression was compared in the primary tumors of patients with recurrence and nonrecurrence to gain insight into the biology of high-risk HER2-positive early breast cancer. Here, ERBB2 is linked to breast carcinoma.